BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28011507)

  • 1. Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular Coagulation.
    Sugiyama K; Narita Y; Kadowaki S; Ura T; Tajika M; Muro K
    Anticancer Res; 2017 Jan; 37(1):309-313. PubMed ID: 28011507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial.
    Hironaka S; Sugimoto N; Yamaguchi K; Moriwaki T; Komatsu Y; Nishina T; Tsuji A; Nakajima TE; Gotoh M; Machida N; Bando H; Esaki T; Emi Y; Sekikawa T; Matsumoto S; Takeuchi M; Boku N; Baba H; Hyodo I
    Lancet Oncol; 2016 Jan; 17(1):99-108. PubMed ID: 26640036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.
    Takashima A; Shirao K; Hirashima Y; Takahari D; Okita NT; Nakajima TE; Kato K; Hamaguchi T; Yamada Y; Shimada Y
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):243-8. PubMed ID: 19727819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer with simultaneous multiple bone metastases and double occurrence of disseminated intravascular coagulation successfully controlled with combined chemotherapy].
    Wakabayashi K; Hayashi S; Masuda H; Karube H; Ookame H; Aoki H; Sakamoto N; Tanaka T; Fujii M; Takayama T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):393-8. PubMed ID: 15045947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful initial treatment with weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin chemotherapy in advanced gastric cancer patients with disseminated intravascular coagulation.
    Chao Y; Teng HC; Hung HC; King KL; Li CP; Chi KH; Yen SH; Chang FY
    Jpn J Clin Oncol; 2000 Mar; 30(3):122-5. PubMed ID: 10798538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of multiple bone metastasis of gastric carcinoma accompanying DIC successfully controlled with combination of S-1 and low-dose CDDP].
    Nishida T; Nakano S; Shida T; Ootsuka T; Ogasawara T; Takahashi M
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):1039-41. PubMed ID: 21677504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11].
    Kitagawa M; Oguro A; Kondo Y; Koh T; Yamasaki J; Nanri M; Nakagawa N
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):165-8. PubMed ID: 20087055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
    Blum M; Suzuki A; Ajani JA
    Future Oncol; 2011 Jun; 7(6):715-26. PubMed ID: 21675835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prominent hypereosinophilia with disseminated intravascular coagulation as an unusual presentation of advanced gastric cancer.
    Takeda H; Nishikawa H; Tsumura T; Sekikawa A; Maruo T; Okabe Y; Kimura T; Wakasa T; Osaki Y
    Intern Med; 2014; 53(6):563-9. PubMed ID: 24633025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
    Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
    Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel].
    Ninomiya K; Mannami T; Seno S; Suzuki Y; Tamura T; Kimura K; Kubo T; Masunari T; Okada T; Kiguchi T; Sezaki N; Harita S; Nakata Y; Sonobe H
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1719-22. PubMed ID: 23152027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
    Senoo S; Mannami T; Tamura T; Fujiwara N; Ikeda G; Komoda M; Ohtawa Y; Fujimoto Y; Sato N; Kambara T; Waku T; Kenmotsu M; Kurimoto E; Okada T; Harita S; Sonobe H
    Gan To Kagaku Ryoho; 2015 Dec; 42(13):2471-5. PubMed ID: 26809307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
    Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
    Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced gastric cancer associated with DIC successfully treated with 5-FU and cisplatin: a case report.
    Matsumoto S; Kiba T; Numata K; Ihata Y; Morita K; Kitamura T; Saito S; Nakatani Y; Tanaka K; Sekihara H
    Hepatogastroenterology; 2002; 49(43):153-6. PubMed ID: 11941941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study.
    Iizumi S; Takashima A; Narita Y; Tajika M; Muro K; Kawai S; Yasui H; Matsushima T; Takahari D; Nagashima K; Boku N
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):575-582. PubMed ID: 28730292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.
    Inadomi K; Kusaba H; Matsushita Y; Tanaka R; Mitsugi K; Arimizu K; Hirano G; Makiyama A; Ohmura H; Uchino K; Hanamura F; Shibata Y; Kuwayama M; Esaki T; Takayoshi K; Arita S; Ariyama H; Akashi K; Baba E
    Anticancer Res; 2017 May; 37(5):2663-2671. PubMed ID: 28476842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of FOLFOX in Advanced Gastric Cancer Initially Presenting With Disseminated Intravascular Coagulation.
    Takahashi N; Ando T; Motoo I; Sakumura M; Ueda Y; Kajiura S; Nakashima K; Hosokawa A; Ueda A; Suzuki N; Nakaya A; Yasuda I
    In Vivo; 2022; 36(5):2447-2452. PubMed ID: 36099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated intravascular coagulation at presentation of advanced gastric cancer.
    Tokar M; Bobilev D; Ariad S; Geffen DB
    Isr Med Assoc J; 2006 Dec; 8(12):853-5. PubMed ID: 17214103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.